Latest News

 Filter by Provider

Integral Ad Science (IAS) beat Q2 2025 earnings with $149.2M revenue (+16% YoY) and $0.07 EPS, driving a 4.3% stock surge. Strong ad verification growth boosts investor confidence.

Cloud storage and e-signature company Dropbox (Nasdaq: DBX) reported Q2 CY2025 results exceeding the market’s revenue expectations, but sales fell by 1.4% year on year to $625.7 million. Its non-GAAP profit of $0.71 per share was 12.3% above analysts’ consensus estimates.

10X Genomics (TXG) reported strong Q2 2025 earnings, beating revenue and EPS estimates, sparking a 4.68% after-hours stock surge. Revenue hit $172.91M, up 22.8%, with EPS at $0.28 vs. expected loss. Growth driven by Chromium & Visium platforms.

Pinterest reports second-quarter revenue of $998.23 million, beating estimates of $974.01 million, according to Benzinga Pro.

Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.

Expedia Group beats Q2 estimates with strong revenue and EPS growth, raises full-year guidance, sparking a 13.7% stock surge. B2B and advertising segments shine.

Instacart (NASDAQ:CART) Q2 2025 earnings beat EPS estimates at $0.41, with $914M revenue matching forecasts. Stock rose 7.39% post-report. Strong order growth signals resilience.

GoDaddy Q2 2025 earnings: $1.22B revenue missed estimates, but $1.41 EPS beat. Stock fell 4.1% amid revenue growth concerns.

HireQuest reported mixed Q2 2025 results, with revenue missing estimates at $7.64M but adjusted EPS beating at $0.15. Cost controls helped offset staffing market softness, while M&A and expense management remain key priorities.

Square's Q2 earnings and revenue slightly missed Wall Street targets. Square stock popped on improving business trends as some key financial metrics beat expectations.

GigaCloud Technology (GCT) beats Q2 2025 estimates with $322.6M revenue (+3.8% YoY) and $0.91 EPS (+40% YoY). Stock surges 8.8% post-earnings on strong marketplace growth.

Consensus Cloud Solutions reported mixed Q2 2025 results with revenue slightly below estimates but adjusted EPS beating forecasts. Corporate growth offset SoHo declines, while cash flow improved. Shares fell 13% amid revenue concerns.

Twilio reports financial results for the second quarter Thursday after the market close. Here's a look at the key details from the report.

Instacart stock jumped following Maplebear's Q2 earnings report, which showed 11% sales growth for the grocery-delivery company.

CytomX Therapeutics (CTMX) Q2 2025 revenue beat estimates at $18.66M, with break-even EPS. Shares rose slightly as clinical progress, including CX-2051 data, boosts optimism.

Restaurant company Texas Roadhouse (NASDAQ:TXRH) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 12.7% year on year to $1.51 billion. Its GAAP profit of $1.86 per share was 2.8% below analysts’ consensus estimates.

Turtle Beach (TBCH) reported mixed Q2 2025 results, missing revenue estimates but improving margins and narrowing losses. Shares fell 6.66% post-earnings despite cost-saving progress. Full-year guidance remains unchanged.

Expensify Inc. (EXFY) reported Q2 2025 revenue growth of 7% to $35.8M but posted a wider-than-expected loss of -$0.10 EPS. Shares fell 7.2% amid investor concerns despite FCF growth and UK/EU card expansion.

VTEX Q2 2025 earnings show mixed results: revenue missed estimates at $58.8M, but subscription growth and profitability improved. Shares fell 3.7% post-announcement.

Slow sales and falling free cash flow have given Yeti investors the shivers.

Here's a look a the Q2 report from Block.

Solventum Corp (NYSE:SOLV) reported mixed Q2 2025 earnings, beating EPS estimates at $1.69 but slightly missing revenue forecasts. Shares rose 3% post-announcement.

Corvus Pharmaceuticals reported a narrower Q2 2025 loss of $0.10 per share, beating estimates, with shares rising 5.8% after-hours. Positive Phase 1 data for soquelitinib in atopic dermatitis boosted investor optimism.

APYX Medical Corp reported Q2 2025 results with revenue of $11.37M, missing estimates, but a narrower EPS loss of -$0.09. Stock shows muted reaction amid commercial expansion plans.

Rocket Lab reports second-quarter financial results after the market close on Thursday. Here's a rundown of the report.

Dianthus Therapeutics Q2 2025 earnings show revenue miss but EPS in line. Cash reserves strong, key clinical trials progressing with major data readouts expected in 2025-2026.

Texas Roadhouse Q2 2025 earnings missed revenue and EPS estimates, triggering a 2.7% stock drop. Dividend maintained at $0.68/share. Analysts provide Q3 and full-year forecasts.

Fertility benefits company Progyny (NASDAQ:PGNY) reported Q2 CY2025 results exceeding the market’s revenue expectations, with sales up 9.5% year on year to $332.9 million. Guidance for next quarter’s revenue was optimistic at $297.5 million at the midpoint, 2% above analysts’ estimates. Its non-GAAP profit of $0.48 per share was 12.1% above analysts’ consensus estimates.

PTC Therapeutics (PTCT) reported strong Q2 2025 earnings, beating revenue estimates at $179M and narrowing EPS loss. Growth driven by Sephience™ launch for PKU in U.S. & Europe. Stock up 5.4% in a month.

Intel shares tumbled more than 3% after President Donald Trump demanded CEO Lip‑Bu Tan resign over alleged conflicts related to China.

Monster Beverage Corp (MNST) reports mixed Q2 2025 results: EPS beats estimates at $0.52, while revenue slightly misses at $2.11B. Shares rise 3.8% post-earnings.

Arrowhead Pharmaceuticals reported mixed Q3 2025 results, beating revenue estimates but missing on EPS. Stock fell 5.3% as higher R&D costs widened losses. Key pipeline updates include plozasiran NDA submission and Phase 3 trial progress.

AudioEye Inc. reports mixed Q2 2025 results with record revenue but misses estimates, sparking a 10% stock drop. EPS beats forecasts, but revenue shortfall drives negative market reaction.

Akamai Technologies (AKAM) reported strong Q2 2025 earnings, beating revenue and EPS estimates with 7% YoY growth. Cloud Infrastructure surged 30%, driving a 3% after-hours stock rise.